Olanzapine, Samidorphan Dual Therapy Well Tolerated in Schizophrenia
Researchers report on the 52-week extension of the ENLIGHTEN-2 study that assessed the long-term safety and efficacy of treatment schizophrenia with olanzapine and samidorphan.
Schizophrenia
Weight Gain During Mental Health Treatment May Negatively Impact Hopefulness, Medication Attitudes, and Depression
Researchers conducted a study to investigate the bidirectional nature of the relationship between obesity and depression.
Extrapyramidal Symptoms in Schizophrenia Associated With Higher Healthcare Costs
Extrapyramidal symptoms that developed in patients with schizophrenia after initiation of treatment with atypical antipsychotic agents were associated with increased healthcare resources and costs.
Weight Gain, Treatment Interruptions Reported With Second-Generation Antipsychotics for Schizophrenia, Bipolar 1 Disorder
Research was conducted to assess the impact of initiation of treatment with second-generation antipsychotics and treatment interruptions on weight gain in patients with schizophrenia and bipolar 1 disorder.
Suicide Rate Up for Schizophrenia Spectrum Disorders
Overall, 1.71% of individuals with a first lifetime diagnosis of schizophrenia, schizoaffective disorder, or psychotic disorder not otherwise specified die by suicide.
Relapse More Likely With Antipsychotic Switch in Schizophrenia, Bipolar Disorder, or MDD
Patients with schizophrenia or a mood disorder who switched antipsychotic treatment had an increased likelihood for relapse, healthcare resource utilization, and extrapyramidal symptoms.
Some Nutritional Supplements May Aid Mental Health Conditions
Nutrient supplements had good safety profiles, no known contraindications with psychiatric medications.
Long-Term Cognitive Decline Found in Schizophrenia and Other Psychoses
Researchers found data that showed, after a 10-year period, a slight decline for the intelligence quotient of patients with schizophrenia.
Better Outcomes in Pediatric-Onset vs Adult-Onset Bipolar Disorder
Individuals with pediatric-onset bipolar disorder fare better than individuals diagnosed at a later age with the disorder, and bipolar disorder in general is associated with better outcomes than schizophrenia.
Comorbid Diabetes, Schizophrenia Increase Hyperglycemic Episode Risk
Findings showed a higher incidence of hyperglycemic episodes in patients with diabetes and comorbid schizophrenia than in those without schizophrenia.
- Loading...
Loading...
Next post in Diabetes Information Center
Loading... 
Loading...